Merck Prevails In Bellwether Fosamax Case

Law360, New York (May 5, 2010, 6:29 PM EDT) -- Merck & Co. Inc. won a unanimous jury verdict Wednesday that dismissed a bellwether case in multidistrict litigation involving the osteoporosis drug Fosamax.

The jury in the U.S. District Court for the Southern District of New York rejected the claims of Louise Maley, who blamed her dental and jaw-related problems on her Fosamax use, according to Merck.

“We believe the company acted properly,” said Christy Jones, an attorney at Butler Snow O'Mara Stevens & Cannada PLLC who served as outside counsel for Merck. “Unfortunately, the plaintiff...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Koor v. Merck & Co., Inc.


Case Number

1:06-cv-04110

Court

New York Southern

Nature of Suit

Personal Inj. Prod. Liability

Judge

John F. Keenan

Date Filed

May 30, 2006

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.